For children, ITP prognosis varies by age, infection status: Study
Older children with immune thrombocytopenia (ITP) who had had an infection tended to achieve sufficient levels of platelets — the cell fragments lost in…
Lindsey Shapiro, PhD, —
Articles by Lindsey Shapiro
Combo of blood biomarkers can help predict risk of death in TTP
A combination of blood biomarkers can help predict the short-term risk of death for people admitted to the hospital with thrombotic thrombocytopenic purpura (TTP),…
Lupus may alter iTTP symptoms, outcomes: Study
People with immune-mediated thrombotic thrombocytopenic purpura (iTTP) who also have systemic lupus erythematosus (SLE) — have different symptoms and longer periods without disease relapse…
Boosting platelet counts in ITP is aim of efgartigimod study
A Phase 3 trial testing efgartigimod administered into a vein in adults with primary immune thrombocytopenia (ITP) is still enrolling participants and its top-line…
Diagnosing, treating TTP promptly improves pregnancy outcomes
Acquired thrombotic thrombocytopenic purpura (TTP) during pregnancy must be distinguished from other conditions, monitored carefully, and treated promptly to ensure the best possible outcomes…
Doptelet found safe, effective in previously treated children with ITP
Doptelet (avatrombopag) was safe and effective in children with immune thrombocytopenia (ITP) who had an insufficient response to previous treatments, according to recently…
